Cancer Genetics Department

The Cancer Genetics Department is located in the Motamed Cancer Institute (MCI). The main missions of the group include studying the cellular, molecular and genetic and epigenetic aspects of breast cancer, including the procedures involved in the diagnosis, prognosis,and response to treatment of breast cancer to find biomarkers related to personalized medicine of cancer.Our service provides comprehensive counselling to individuals with a family history of cancer.  This process involves constructing detailed family histories, conducting the risk assessment, arranging screening/ genetic analysis/ testing, if necessary, and providing ongoing support. 

Perspectives

• Determining breast cancer risks and providing genetic counseling in familial cancer clinics

• Measuring and studying the the relationship between relevant molecular markers and prognosis, overall survival and treatment response in patients with breast cancer, focusing on liquid biopsy, including exosomes and circulating tumor cells and cell free nucleic acids as a new source of biomarkers
• Investigating genetics and epigenetics, specially non-coding RNAs of drug resistance that could lead to new therapies and better treatment decisions for breast tumors
• Cytogenetic studies over breast cancer and attention to cancer stem cells
• Using bioinformatics and system biology approaches for biomarker detection

We are pleased to announce that we have revised and improved the structure and curriculum of our graduate programs to create M.S. and Ph.D. degrees in Cancer Sciences and ready to conduct joint projects with other breast cancer research centers

Cancer genetics department has formed strong alliances with universities and other local and regional institutes and colleges to provide superior, comprehensive research and education in several fields.